Abstract: We introduce NeRD, a new demosaicking method for generating full-color images from Bayer patterns. Our approach leverages advancements in neural fields to perform demosaicking by ...

With the 2025/26 season about half gone, it is high time that new kit designs for the following season slowly get leaked out ...

The Trump administration has diverged from the position of former US President Joe Biden, throwing its weight behind German chemical giant Bayer in its courtroom ...

The Trump administration has urged the U.S. Supreme Court to hear Bayer's case aimed at stopping thousands of cancer lawsuits over its Roundup weedkiller. Bayer CEO Bill Anderson joined "The Claman ...

Bayer’s oral FXIa inhibitor asundexian has significantly reduced the risk of stroke in a phase 3 trial, giving a boost to a potentially blockbuster mechanism that has suffered setbacks over the past ...

Litigation costs seen impacting 2025 reported earnings CEO has said aims to resolve most glyphosate cases by 2026 Bayer has cut 13,500 jobs to speed up decision making FRANKFURT, Nov 12 (Reuters) - ...

Bayer has cleared out four cancer candidates from its early-stage pipeline, including a STAT3 inhibitor acquired as part of its buyout of Vividion Therapeutics. The Vividion asset in question, called ...

Bayer’s Roundup pesticide is linked with cancer. Its multi-million dollar fight to evade justice and accountability threatens to leave sick people holding the bag. Bayer’s Roundup pesticide is linked ...

When Bayer CEO Bill Anderson launched his Dynamic Shared Ownership (DSO) layoff plan—designed to save 2 billion euros ($2.3 billion) in 2026—he said it would be completed by the “end of 2025 at the ...

July 31 (Reuters) - German pharmaceutical and biotechnology group Bayer (BAYGn.DE), opens new tab said on Thursday it had set aside an additional 1.2 billion euros ($1.37 billion) in provisions to ...

Bayer A.G.'s stock is very cheap and near multi-year lows, but ongoing declines and uncertain turnaround make it risky for conservative investors. Pharmaceuticals and consumer health divisions are ...